Abstract | BACKGROUND AND OBJECTIVES: Systemic failure remains a predominant issue in locally advanced rectal cancer (LARC). A new strategy using capecitabine and oxaliplatin ( XELOX regimen) administered prior to and then concomitant to radiotherapy for high risk LARC is developed in our practice. The aim of the present study was to evaluate the short-term efficacy and toxicities of this strategy. METHODS: Patients were treated with one cycle XELOX regimen ( oxaliplatin 130 mg/m(2) on day 1 with capecitabine 1,000 mg/m(2) twice daily for 14 days every 3 weeks), followed by chemoradiation (50 Gy over 5 weeks) with modified XELOX regimen ( oxaliplatin dose reduction to 100 mg/m(2)), and total mesorectal excision. Tumor response, toxicities, and surgical complications were recorded. RESULTS: CONCLUSIONS:
|
Authors | Yuan-Hong Gao, Xin An, Wei-Jiang Sun, Juan Cai, Mu-Yan Cai, Ling-Heng Kong, Jun-Zhong Lin, Guo-Chen Liu, Jing-Hua Tang, Xiao-Jun Wu, Gong Chen, Zhi-Zhong Pan, Pei-Rong Ding |
Journal | Journal of surgical oncology
(J Surg Oncol)
Vol. 109
Issue 5
Pg. 478-82
(Apr 2014)
ISSN: 1096-9098 [Electronic] United States |
PMID | 24288203
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2013 Wiley Periodicals, Inc. |
Chemical References |
- Organoplatinum Compounds
- Oxaliplatin
- Deoxycytidine
- Capecitabine
- Fluorouracil
|
Topics |
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage, adverse effects)
- Capecitabine
- Chemoradiotherapy
- China
- Databases, Factual
- Deoxycytidine
(administration & dosage, adverse effects, analogs & derivatives)
- Diarrhea
(etiology)
- Digestive System Surgical Procedures
(adverse effects, methods)
- Drug Administration Schedule
- Female
- Fluorouracil
(administration & dosage, adverse effects, analogs & derivatives)
- Humans
- Induction Chemotherapy
(adverse effects, methods)
- Male
- Middle Aged
- Neoadjuvant Therapy
(methods)
- Neoplasm Staging
- Organoplatinum Compounds
(administration & dosage, adverse effects)
- Oxaliplatin
- Proctitis
(etiology)
- Radiodermatitis
(etiology)
- Rectal Neoplasms
(pathology, therapy)
- Remission Induction
- Severity of Illness Index
- Thrombocytopenia
(etiology)
- Treatment Outcome
|